LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organisations, announces the promotion of three executives to top-level management positions: Barry Simms, MBA, as Chief Operating Officer, Trenton Harris, MSM/MBA, as Executive Vice President and Elizabeth Koury, MS, as Vice President, Scientific Affairs. All three executives bring a wealth of biopharmaceutical industry skills and experience to the company.
Simms will oversee LabConnect’s operations and growth as Chief Operating Officer. Simms began his career over 18 years ago as a Clinical Research Associate and has held positions of increasing responsibility since then.
As Executive Vice President, Harris brings a diverse skill set and over 20 years of extensive clinical trials experience to LabConnect. Harris combines both deep financial planning and analysis expertise with an understanding of the importance of employee engagement to ensure superior customer service. Prior to LabConnect, Harris was a Senior Executive in drug development for Covance’s central laboratory and safety division.
Koury joined LabConnect in 2012 following more than 15 years of conducting and overseeing scientific research focused in neuroscience, oncology and immunology. As Vice President of Scientific Affairs, she oversees scientific operations (SciOps) and technical affairs. Koury will accelerate the growth of SciOps and formalise LabConnect’s technical support functions to benefit clients.
“We are pleased to have these three executives on our team and to acknowledge their hard work and ongoing contributions to LabConnect’s success,” said Eric Hayashi, MBA, President and CEO of LabConnect. “Their continued expertise and dedication to our company’s mission creates long-term value for our clients.”
